4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001209191-16-142260
Chief Operating Officer sold 714 shares at $2.89 ($2,063)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Keuer Thomas A Chief Operating Officer | 2016-09-20 | Sale | −714 | $2.89 | $2,063 | 15,383 | D |
| Open-market sales · 714 sh · avg $2.89 · $2,063 | |||||||
Loading xslF345X03/doc4.xml…